JPRN-UMIN000045226已完成未知
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndrome - Effects of treatment with SGLT2 inhibitor on the initiation of C-PAP therapy in type 2 diabetic patients with OSAS
Akishima Clinic0 个研究点目标入组 16 人开始时间: 2021年8月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •eGFR<45 mL/min/1.73 m2
研究者
相似试验
已完成
不适用
The inhibitory effects of the SGLT2 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.diabetic nephropathy in type 2 diabetes mellitusJPRN-UMIN000016754Saitama Medical Center, Saitama Medical University50
尚未招募
2 期
Mechanisms of action of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction (HFrEF)Heart Failure with Reduced Ejection fractionCardiovascular - Other cardiovascular diseasesACTRN12621000187842The Alfred Hospital36
进行中（未招募）
1 期
The REFORM TrialType 2 diabetes and Heart FailureEUCTR2014-002742-42-GBniversity of Dundee/ NHS Tayside56
招募中
不适用
Influence of SGLT2 inhibitor on myocardial fatty acid metabolismtype 2 diabetesJPRN-jRCT1041190002Kumazaki Setsuo40
尚未招募
Unknown
Observational Study of the effect of SGLT2 inhibitor on Glycemic Control Indicesdiabetes mellitusJPRN-UMIN000050228agoya University4,250